These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2473860)

  • 1. Histamine release from basophils in cystic fibrosis.
    Schönfeld W; Saak A; Steinkamp G; Van der Hardt H; König W
    Clin Exp Immunol; 1989 Jun; 76(3):434-9. PubMed ID: 2473860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [LTB4-metabolism and histamine liberation by granulocytes in the disease pattern of cystic fibrosis (CF)].
    Saak A; Schönfeld W; König W; von der Hardt H
    Pneumologie; 1991 Nov; 45(11):913-23. PubMed ID: 1722312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa allergy in cystic fibrosis. Involvement of histamine release in the pathogenesis of lung tissue damage.
    Skov PS; Norn S; Schiøtz PO; Permin H; Høiby N
    Allergy; 1980 Jan; 35(1):23-9. PubMed ID: 6154430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basophil releasability in the newborn: factors limiting immunoglobulin E-mediated histamine release.
    Mendoza GR; Minagawa K; Orner FB; Stiehm ER
    Pediatrics; 1982 Feb; 69(2):188-92. PubMed ID: 6173838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human basophil releasability. III. Genetic control of human basophil releasability.
    Marone G; Poto S; Celestino D; Bonini S
    J Immunol; 1986 Dec; 137(11):3588-92. PubMed ID: 2431036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of IgE-dependent basophil releasability in allergic patients.
    Sanz ML; Latasa M; García BE; Gato JJ; Oehling A
    J Investig Allergol Clin Immunol; 1991 Oct; 1(5):293-301. PubMed ID: 1727011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human basophil releasability. VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma.
    Casolaro V; Spadaro G; Marone G
    Am Rev Respir Dis; 1990 Nov; 142(5):1108-11. PubMed ID: 1700653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of mediator release from human basophils induced by platelet-activating factor.
    Columbo M; Casolaro V; Warner JA; MacGlashan DW; Kagey-Sobotka A; Lichtenstein LM
    J Immunol; 1990 Dec; 145(11):3855-61. PubMed ID: 1700998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-human IgG causes basophil histamine release by acting on IgG-IgE complexes bound to IgE receptors.
    Lichtenstein LM; Kagey-Sobotka A; White JM; Hamilton RG
    J Immunol; 1992 Jun; 148(12):3929-36. PubMed ID: 1376345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basophil releasability in severely burned patients.
    Bergmann U; König W; Gross-Weege W; Schlüter B; Köller M; Erbs G; Müller FE
    J Trauma; 1990 Nov; 30(11):1372-9. PubMed ID: 1700141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by somatostatin of the release of mediators from human basophils and rat leukemic basophils.
    Goetzl EJ; Payan DG
    J Immunol; 1984 Dec; 133(6):3255-9. PubMed ID: 6208274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basophil histamine release decreases during omalizumab therapy in allergic asthmatics.
    Noga O; Hanf G; Kunkel G; Kleine-Tebbe J
    Int Arch Allergy Immunol; 2008; 146(1):66-70. PubMed ID: 18087163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of IgE on human basophils: relation to serum IgE and anti-IgE-induced histamine release.
    Conroy MC; Adkinson NF; lichtenstein LM
    J Immunol; 1977 Apr; 118(4):1317-21. PubMed ID: 66288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links.
    MacGlashan DW; Peters SP; Warner J; Lichtenstein LM
    J Immunol; 1986 Mar; 136(6):2231-9. PubMed ID: 2419427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgE-dependent regulation of human basophil adherence to vascular endothelium.
    Bochner BS; MacGlashan DW; Marcotte GV; Schleimer RP
    J Immunol; 1989 May; 142(9):3180-6. PubMed ID: 2468714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo characterization of the anti-inflammatory effect of cyclosporin A on human basophils.
    Casolaro V; Spadaro G; Patella V; Marone G
    J Immunol; 1993 Nov; 151(10):5563-73. PubMed ID: 7693814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histamine release and morphological changes in basophilic granulocytes of atopic asthmatics induced by antigen, anti-IgE and Ca ionophore A 23187.
    Tanizaki Y; Nakagawa S; Kimura I
    Arerugi; 1992 May; 41(5):571-6. PubMed ID: 1381575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables.
    MacGlashan DW
    J Allergy Clin Immunol; 1993 Feb; 91(2):605-15. PubMed ID: 7679683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial.
    Ratjen F; Munck A; Kho P; Angyalosi G;
    Thorax; 2010 Apr; 65(4):286-91. PubMed ID: 19996339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of human basophil IgE and FC epsilon RI alpha surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo.
    Saini SS; MacGlashan DW; Sterbinsky SA; Togias A; Adelman DC; Lichtenstein LM; Bochner BS
    J Immunol; 1999 May; 162(9):5624-30. PubMed ID: 10228046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.